Latest News | AstraZeneca Pharma India Shares Jump 2 Pc

New Delhi, Dec 10 (PTI) Shares of AstraZeneca Pharma India on Friday jumped nearly 2 per cent after biopharmaceutical multinational AstraZeneca said it has initiated engagements with Indian health authorities to provide the latest evidence of Evusheld, its COVID-19 prevention drug.

On the BSE, the shares closed at Rs 3,145 higher 1.9 per cent over the previous close. Intra-day, it had touched Rs 3,163.6.

Also Read | OnePlus 9RT & OnePlus Buds Z2 Spotted on India Website, Launch Expected Soon.

On the NSE, the scrip ended at Rs 3,138.5, a gain of 1.58 per cent.

It was trading at an intra-day high value of Rs 3,166.25

Also Read | Health Ministry Undertakes Steps for Wellbeing of COVID Warriors.

In terms of traded volume, over 18,000 shares were traded on the exchanges during the day.

Evusheld is the company's COVID-19 prevention drug for people with the weakened immune system and has received emergency use authorisation (EUA) in the US.

(The above story is verified and authored by Press Trust of India (PTI) staff. PTI, India’s premier news agency, employs more than 400 journalists and 500 stringers to cover almost every district and small town in India.. The views appearing in the above post do not reflect the opinions of LatestLY)